Navigation Links
Renal function and heart disease, and more
Date:9/3/2007

In this weeks press release:

  • Renal function and coronary heart disease
  • Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1

Please mention PLoS Medicine in your report and use the links below to take your readers straight to the online articles:


THE FOLLOWING RESEARCH ARTICLES WILL BE PUBLISHED ONLINE:

Renal function and coronary heart disease

John Danesh and colleagues conclude there may be a moderate increase in risk of coronary heart disease associated with very low estimated glomerular filtration rate.

Citation: Di Angelantonio E, Danesh J, Eiriksdottir G, Gudnason V (2007) Renal function and risk of coronary heart disease in general populations: New prospective study and systematic review. PLoS Med 4(9): e270.

IN YOUR ARTICLE, PLEASE LINK TO THIS URL, WHICH WILL PROVIDE ACCESS TO THE PUBLISHED PAPER: http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0040270

PRESS-ONLY PREVIEW OF THE ARTICLE: http://www.plos.org/press/plme-04-09-danesh.pdf

CONTACT:

John Danesh
University of Cambridge
Institute of Public Health
Dept of Public Health and Primary Care
Strangeways Research Laboratory
Worts Causeway
Cambridge, CB1 8RN
United Kingdom
+44 1223 741302
+44 1223 741339 (fax)
john.danesh@phpc.cam.ac.uk


Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1

Using a mouse model of acute respiratory distress syndrome, Duncan Stewart and colleagues report that rescue with mesenchymal stem cells expressing human angiopoietin 1 can avert lung injury from lipopolysaccharide.

Citation: Mei SHJ, McCarter SD, Deng Y, Parker CH, Liles WC, et al. (2007) Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med 4(9): e269.

IN YOUR ARTICLE, PLEASE LINK TO THIS URL, WHICH WILL PROVIDE ACCESS TO THE PUBLISHED PAPER: http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0040269

PRESS-ONLY PREVIEW OF THE ARTICLE: http://www.plos.org/press/plme-04-09-stewart.pdf

CONTACT:

Duncan Stewart
University of Toronto
St. Michaels Hospital
The Terrence Donnelly Research Laboratories
Toronto, Ontario
Canada
+1 416 864-5724
dustewart@ohri.ca
'/>"/>

Contact: Andrew Hyde
ahyde@plos.org
44-122-346-3330
Public Library of Science
Source:Eurekalert

Related medicine news :

1. Renal problem alleviated
2. Increase in renal problems
3. Effect of drug on Renal Cancer
4. Renal problem increased
5. Drug Spironolactone Provides Renal And Cardioprotection In Diabetic Patients
6. Acute Toxicity Of Nano-Scale Zinc Powder: Severe Renal Damage And Anemia
7. A Novel Method Of Detection Of High Nuclear Grade Localized Renal Cell Carcinoma
8. Negative Impact Of Hepatitis C Infection In Renal Transplant Recipients
9. Clinical Renal Trails Do Not Have Sufficient Women Participants
10. Adrenal Suppression not predicted by inhaled corticosteroids
11. Sunitinib a Promising Agent for Treatment of Renal Cell Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... 08, 2016 , ... The West Virginia Medical Institute (WVMI) ... The name change aligns the entire company with its existing Quality Insights branded ... “We are very proud of the achievements associated with the West Virginia Medical ...
(Date:12/8/2016)... ... 2016 , ... Russ DiGilio , founder and owner ... campaign which supported local breast cancer organizations during National Breast Cancer Awareness Month ... initiative, and we’re very pleased with the participation in every franchisee’s community,” ...
(Date:12/8/2016)... ... 2016 , ... Mirixa Corporation , a leading healthcare ... patient care services, has announced the promotions of Karen Litsinger to senior vice ... sales. , Litsinger joined Mirixa in 2008 after serving as a partner ...
(Date:12/8/2016)... Boston (PRWEB) , ... December 08, 2016 , ... ... shareholders with global law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. ... sponsor of the DeviceTalks series, and attorneys from the firm’s global Life Sciences & ...
(Date:12/8/2016)... ... December 08, 2016 , ... Launching ... innovative Unified Instance Manager architecture, meeting the needs of multichannel growth and ... the unattended auto-dialing system without agents, Presence Robodialer, provides greater operational capacity, ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 IRIDEX Corporation (NASDAQ: ... offer newly issued shares of common stock, $0.01 par value ... an underwritten public offering.  The final terms of the Offering ... of pricing, and there can be no assurance as to ... IRIDEX expects to use the net proceeds it will receive ...
(Date:12/8/2016)... -- Australia Glaucoma Surgery Devices Market Outlook to ... Glaucoma Surgery Devices Market Outlook to 2022", provides ... Devices market. The report provides value, in millions ... prices (USD) within market segement - Glaucoma Drainage ... and distribution shares data for each of these ...
(Date:12/8/2016)... 2016  The global biosurgery market is expected to ... period of 2016 to 2021. The market is poised ... 18.21 billion in 2016. The market is primarily driven ... related injuries and spinal problems, increasing clearance of biosurgery ... blood loss management. In this report, the ...
Breaking Medicine Technology: